Videos

Second Acts – Reinventing Your Company

By Tom Salemi | December 2, 2014

Building a successful biotech or biopharma company typically turns on a sentinel event – the pivot, as William J. Link, PhD, Managing Director of Versant…

Read More

The Ophthalmology Market – A View Of The Public Sector & Exit Trends

By Tom Salemi | December 2, 2014

Jeffrey Hoffman, Managing Director and Head of West Coast Healthcare Investment Banking for J.P. Morgan, told attendees at the Ophthalmology Innovation Summit in Chicago how…

Read More

i-Optics

By Tom Salemi | December 1, 2014

[creativ_media type=”vimeo” url=”https://vimeo.com/111856584″] Presenter: Jeroen Cammeraat Jeroen Cammeraat is CEO of i-Optics and investor in the company since 2010. A serial entrepreneur and Senior Executive…

Read More

InnFocus

By Tom Salemi | November 25, 2014

InnFocus Inc.’s MicroShunt glaucoma drainage implant is designed to reduce intraocular pressure in glaucoma patients. President and CEO Russell Trenary explained that the implant is…

Read More

Avedro

By Tom Salemi | November 25, 2014

Avedro’s KXL® System for accelerated cross-linking, as well as a family of riboflavin products, have been commercially available since 2010. Refractive correction pioneer and veteran David…

Read More

ForSight VISION5

By Tom Salemi | November 25, 2014

ForSight VISION5 Inc. CEO John Maroney discussed his company’s novel, non-invasive insert system, Helios. Placed on the surface of the eye, under the eyelid, Helios…

Read More

Implandata Ophthalmic Products GmbH

By Tom Salemi | November 25, 2014

Implandata Ophthalmic Products GmbH is developing a patient-operated, hand-held system, which works with an implantable micro sensor capable of measuring absolute intraocular pressure continuously or…

Read More

IOPtima

By Tom Salemi | November 25, 2014

Ronen Castro, CEO of Israeli company IOPtima Ltd., introduced the CLASS (CO2 Laser-Assisted Sclerectomy Surgery) procedure for glaucoma, which has results comparable to trabeculectomy, but…

Read More

Mati Therapeutics

By Tom Salemi | November 25, 2014

Mati Therapeutics Inc. is an early-stage company addressing the massive glaucoma market. Founder and CEO Robert Butchofsky discussed the main challenges to all glaucoma-focused sustained…

Read More

Neurotech

By Tom Salemi | November 25, 2014

Quinton Oswold, President and CEO of Neurotech Pharmaceuticals Inc., sees huge opportunity both in wet AMD and diabetic macular edema patients who need more extensive…

Read More

PowerVision

By Tom Salemi | November 25, 2014

PowerVision Inc.’s FluidVision, an intraocular lens designed to treat presbyopia and/or cataracts, is the only technology that restores true accommodation, reported company President and CEO…

Read More

TearScience

By Tom Salemi | November 25, 2014

TearScience Inc. CEO and Co-Founder Tim Willis emphasized that his company was founded for a single reason: to be the evaporative dry eye expert, and…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.